SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-20-001500
Filing Date
2020-02-26
Accepted
2020-02-26 17:28:28
Documents
104
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K clvs-20191231x10k5eb4cb.htm   iXBRL 10-K 3668062
2 EX-4.6 ex-4d6.htm EX-4.6 30967
3 EX-23.1 ex-23d1.htm EX-23.1 5480
4 EX-31.1 ex-31d1.htm EX-31.1 19872
5 EX-31.2 ex-31d2.htm EX-31.2 19872
6 EX-32.1 ex-32d1.htm EX-32.1 7990
7 EX-32.2 ex-32d2.htm EX-32.2 8032
8 GRAPHIC clvs-20191231x10k5eb4cb006.jpg GRAPHIC 81117
9 GRAPHIC clvs-20191231x10k5eb4cb008.jpg GRAPHIC 57792
  Complete submission text file 0001558370-20-001500.txt   14096696

Data Files

Seq Description Document Type Size
10 EX-101.SCH clvs-20191231.xsd EX-101.SCH 77684
11 EX-101.CAL clvs-20191231_cal.xml EX-101.CAL 111243
12 EX-101.DEF clvs-20191231_def.xml EX-101.DEF 256975
13 EX-101.LAB clvs-20191231_lab.xml EX-101.LAB 788962
14 EX-101.PRE clvs-20191231_pre.xml EX-101.PRE 560264
64 EXTRACTED XBRL INSTANCE DOCUMENT clvs-20191231x10k5eb4cb_htm.xml XML 2721263
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35347 | Film No.: 20657299
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences